Allergan To Pay $300M For Glaucoma Treatment Developer
Overview
McDermott provided advice on intellectual property matters to AqueSys Inc. in the company’s acquisition by a global pharmaceutical firm. AqueSys makes an implantable device for alleviating eye pressure related to glaucoma.
